ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 125 filers reported holding ANI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $121,000 | -40.1% | 3,455 | -51.8% | 0.00% | -100.0% |
| Q3 2020 | $202,000 | -89.2% | 7,171 | -87.6% | 0.00% | -87.5% |
| Q2 2020 | $1,877,000 | +2.8% | 57,962 | +29.3% | 0.01% | -20.0% |
| Q1 2020 | $1,826,000 | +6.4% | 44,844 | +61.0% | 0.01% | +25.0% |
| Q4 2019 | $1,716,000 | +380.7% | 27,860 | +467.9% | 0.01% | +300.0% |
| Q3 2019 | $357,000 | +0.6% | 4,906 | +14.0% | 0.00% | 0.0% |
| Q2 2019 | $355,000 | -38.6% | 4,302 | -47.4% | 0.00% | 0.0% |
| Q1 2019 | $578,000 | +150.2% | 8,176 | +59.6% | 0.00% | +100.0% |
| Q4 2018 | $231,000 | -36.0% | 5,122 | -19.8% | 0.00% | 0.0% |
| Q3 2018 | $361,000 | -88.5% | 6,387 | -92.0% | 0.00% | -94.1% |
| Q3 2015 | $3,145,000 | +3318.5% | 79,611 | +5301.0% | 0.02% | – |
| Q1 2015 | $92,000 | +114.0% | 1,474 | +93.9% | 0.00% | – |
| Q4 2014 | $43,000 | – | 760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |